The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-10

Study Completion Date

2020-09-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Lung Ultrasonography in COVID-19 Pneumonia

NCT04719234

Lung Ultrasound Pneumonia Covid19

COMPLETED NA

Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia

NCT04805684

Lung Ultrasound Pneumonia Covid19

COMPLETED NA

Correlation Between Thoracic Ultrasound and Thorax Computed Tomography Scores.

NCT04577235

COVID-19

COMPLETED NA

Lung Ultrasound to Diagnose COVID-19

NCT04368338

Covid-19 Lung Ultrasound Respiratory Complication

COMPLETED

Lung Ultrasound for COVID-19 Initial Triage and Monitoring

NCT04474236

COVID-19 Acute Respiratory Failure Triage +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Novel Coronavirus 2019 Disease (COVID-19) mortality is highly associated with viral pneumonia and its complications. Accurate and prompt diagnosis shown to be effective to improve outcome by providing early treatment strategies. While chest X-ray (CXR) and computerized tomography (CT) are defined as gold standard, given the advantage of being an ionized radiation free, practical technique point of care ultrasound (POCUS) is also reported as a diagnostic tool for COVID-19. There are limited studies regarding the importance of POCUS in diagnosis and review of COVID-19. Therefore the aim of this study is to evaluate the utility of bedside lung ultrasound on diagnosis of COVID-19 for patients admitted to emergency department .

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID Pneumonia, Viral

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Suspected COVID-19 Group

Patients who admitted to emergency department with suspicion of COVID 19 pneumonia will be evaluated with POCUS/ bedside lung ultrasound.

Group Type OTHER

Bedside lung ultrasound

Intervention Type DEVICE

Point of care ultrasound will be used as bedside lung ultrasound to determine the patients if they have a COVID-19 pneumonia.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bedside lung ultrasound

Point of care ultrasound will be used as bedside lung ultrasound to determine the patients if they have a COVID-19 pneumonia.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients with an informed consent
* Admission to emergency department with symptoms or signs of COVID-19

Exclusion Criteria

* Absence of informed consent
* Patients under age of 18
* Presence of acute coronary syndrome
* Presence of chronic lung disease
* Pregnancy
* Presence of trauma
* Patients with a diagnosis of malignancy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No